A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030
In a potential marriage that analysts said faces long odds, AstraZeneca and Bristol Myers Squibb have held talks…
AstraZeneca in Talks to Merge With Bristol Myers Squibb in Potential $400B Pharma Megadeal — BigGo Finance
UK drugmaker AstraZeneca has held exploratory talks with US rival Bristol Myers Squibb about a potential merger that…